Based on the results from the online tools, we found that the mRNA expression of DRD3 was associated with RFS, OS, PFS and DSS in HCC patients, while DRD3 gene mutation was also related to the survival of patients (P < 0.05). The gene discussed is DRD3; the disease is hepatocellular carcinoma.